SCHEMBL14084248

SCHEMBL14084248

Nc1nc(OC[C@@H]2CCN2)c2c(n1)-c1ccccc1CCC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 8/20 0.50
▸ BCHE P06276 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.40
▸ POLB P06746 1/20 0.40
▸ CCNA2 P20248 2/20 0.39
▸ CDK2 P24941 2/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CCNB1 P14635 1/20 0.39
▸ ADORA2A P29274 2/20 0.38
▸ ADORA1 P30542 2/20 0.38
▸ HRH3 Q9Y5N1 3/20 0.38
▸ HRH2 P25021 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ CHRNA3 P32297 2/20 0.35
▸ CHRNA7 P36544 2/20 0.35
▸ CHRNA1 P02708 1/20 0.35
▸ CHRNG P07510 1/20 0.35
▸ CHRNB1 P11230 1/20 0.35
▸ CHRNB2 P17787 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14084203 0.94 HRH4 (0.48) HRH4BCHECHRNA3CHRNB2CHRNB4
SCHEMBL14084202 0.94 HRH4 (0.48) HRH4BCHECHRNA3CHRNB2CHRNB4
SCHEMBL14084204 0.93 HRH4 (0.47) HRH4BCHECCNA2CDK2CDK1
SCHEMBL14084205 0.93 HRH4 (0.47) HRH4BCHECCNA2CDK2CDK1
SCHEMBL14084162 0.78 HRH4 (0.53) HRH4BCHEKDM4EALDH1A1POLB
SCHEMBL602935 0.78 HRH4 (0.53) HRH4BCHEKDM4EALDH1A1POLB
SCHEMBL602388 0.78 HRH4 (0.57) HRH4BCHEKDM4EALDH1A1POLB
SCHEMBL605673 0.77 HRH4 (0.51) HRH4BCHEADORA2AADORA1HRH3
SCHEMBL606491 0.76 HRH4 (0.53) HRH4BCHEKDM4EALDH1A1POLB
SCHEMBL14084245 0.76 HRH4 (0.53) HRH4BCHEKDM4EALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 — — US disclosed
US-8735411-B2 Macrocyclic benzofused pyrimidine derivatives ABBVIE INC. (US) 2014-05-27 — — US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 — — US disclosed
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives ABBVIE INC. 2008-08-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188452-A1 Macrocyclic Benzofused Pyrimidine Derivatives DPYD, TYMS, UMPS HRH4 3013/4885BCHE 1235/4885KDM4E 1709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback